1
|
Membrane-Binding Mechanism of Clostridium perfringens Alpha-Toxin. Toxins (Basel) 2015; 7:5268-75. [PMID: 26633512 PMCID: PMC4690130 DOI: 10.3390/toxins7124880] [Citation(s) in RCA: 56] [Impact Index Per Article: 6.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/27/2015] [Revised: 11/17/2015] [Accepted: 11/30/2015] [Indexed: 12/11/2022] Open
Abstract
Clostridium perfringens alpha-toxin is a key mediator of gas gangrene, which is a life-threatening infection that manifests as fever, pain, edema, myonecrosis, and gas production. Alpha-toxin possesses phospholipase C and sphingomyelinase activities. The toxin is composed of an N-terminal domain (1-250 aa, N-domain), which is the catalytic site, and a C-terminal domain (251-370 aa, C-domain), which is the membrane-binding site. Immunization of mice with the C-domain of alpha-toxin prevents the gas gangrene caused by C. perfringens, whereas immunization with the N-domain has no effect. The central loop domain (55-93 aa), especially H….SW(84)Y(85)….G, plays an important role in the interaction with ganglioside GM1a. The toxin binds to lipid rafts in the presence of a GM1a/TrkA complex, and metabolites from phosphatidylcholine to diacylglycerol through the enzymatic activity of alpha-toxin itself. These membrane dynamics leads to the activation of endogenous PLCγ-1 via TrkA. In addition, treatment with alpha-toxin leads to the formation of diacylglycerol at membrane rafts in ganglioside-deficient DonQ cells; this in turn triggers endocytosis and cell death. This article summarizes the current the membrane-binding mechanism of alpha-toxin in detail.
Collapse
|
2
|
Zheng LH, Wang CH, Shang SJ, Zhang XY, Wang YS, Wu QH, Hu MQ, Chai ZY, Wu X, Zheng H, Zhang C, Wang LC, Xiong W, Zhou Z. Real-time endocytosis imaging as a rapid assay of ligand-GPCR binding in single cells. Am J Physiol Cell Physiol 2013; 305:C751-60. [DOI: 10.1152/ajpcell.00335.2012] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/19/2023]
Abstract
Most G protein-coupled receptors (GPCRs) do not generate membrane currents in response to ligand-receptor binding (LRB). Here, we describe a novel technique using endocytosis as a bioassay that can detect activation of a GPCR in a way analogous to patch-clamp recording of an ion channel in a living cell. The confocal imaging technique, termed FM endocytosis imaging (FEI), can record ligand-GPCR binding with high temporal (second) and spatial (micrometer) resolution. LRB leads to internalization of an endocytic vesicle, which can be labeled by a styryl FM dye and visualized as a fluorescent spot. Distinct from the green fluorescence protein-labeling method, FEI can detect LRB endocytosis mediated by essentially any receptors (GPCRs or receptors of tyrosine kinase) in a native cell/cell line. Three modified versions of FEI permit promising applications in functional GPCR studies and drug screening in living cells: 1) LRB can be recorded in “real time” (time scale of seconds); 2) internalized vesicles mediated by different GPCRs can be discriminated by different colors; and 3) a high throughput method can screen ligands of a specific GPCR.
Collapse
Affiliation(s)
- Liang-Hong Zheng
- State Key Laboratory of Biomembrane and Membrane Biotechnology and Beijing Key Laboratory of Cardiometabolic Molecular Medicine and PKU-IDG/McGovern Institute for Brain Research, Institute of Molecular Medicine and Peking-Tsinghua Center for Life Sciences, Peking University, Beijing, China
| | - Chang-He Wang
- State Key Laboratory of Biomembrane and Membrane Biotechnology and Beijing Key Laboratory of Cardiometabolic Molecular Medicine and PKU-IDG/McGovern Institute for Brain Research, Institute of Molecular Medicine and Peking-Tsinghua Center for Life Sciences, Peking University, Beijing, China
| | - Shu-Jiang Shang
- State Key Laboratory of Biomembrane and Membrane Biotechnology and Beijing Key Laboratory of Cardiometabolic Molecular Medicine and PKU-IDG/McGovern Institute for Brain Research, Institute of Molecular Medicine and Peking-Tsinghua Center for Life Sciences, Peking University, Beijing, China
| | - Xiao-Yu Zhang
- State Key Laboratory of Biomembrane and Membrane Biotechnology and Beijing Key Laboratory of Cardiometabolic Molecular Medicine and PKU-IDG/McGovern Institute for Brain Research, Institute of Molecular Medicine and Peking-Tsinghua Center for Life Sciences, Peking University, Beijing, China
| | - Ye-Shi Wang
- State Key Laboratory of Biomembrane and Membrane Biotechnology and Beijing Key Laboratory of Cardiometabolic Molecular Medicine and PKU-IDG/McGovern Institute for Brain Research, Institute of Molecular Medicine and Peking-Tsinghua Center for Life Sciences, Peking University, Beijing, China
| | - Qi-Hui Wu
- State Key Laboratory of Biomembrane and Membrane Biotechnology and Beijing Key Laboratory of Cardiometabolic Molecular Medicine and PKU-IDG/McGovern Institute for Brain Research, Institute of Molecular Medicine and Peking-Tsinghua Center for Life Sciences, Peking University, Beijing, China
| | - Mei-Qin Hu
- State Key Laboratory of Biomembrane and Membrane Biotechnology and Beijing Key Laboratory of Cardiometabolic Molecular Medicine and PKU-IDG/McGovern Institute for Brain Research, Institute of Molecular Medicine and Peking-Tsinghua Center for Life Sciences, Peking University, Beijing, China
| | - Zu-Yin Chai
- State Key Laboratory of Biomembrane and Membrane Biotechnology and Beijing Key Laboratory of Cardiometabolic Molecular Medicine and PKU-IDG/McGovern Institute for Brain Research, Institute of Molecular Medicine and Peking-Tsinghua Center for Life Sciences, Peking University, Beijing, China
| | - Xi Wu
- State Key Laboratory of Biomembrane and Membrane Biotechnology and Beijing Key Laboratory of Cardiometabolic Molecular Medicine and PKU-IDG/McGovern Institute for Brain Research, Institute of Molecular Medicine and Peking-Tsinghua Center for Life Sciences, Peking University, Beijing, China
| | - Hui Zheng
- State Key Laboratory of Biomembrane and Membrane Biotechnology and Beijing Key Laboratory of Cardiometabolic Molecular Medicine and PKU-IDG/McGovern Institute for Brain Research, Institute of Molecular Medicine and Peking-Tsinghua Center for Life Sciences, Peking University, Beijing, China
| | - Chen Zhang
- State Key Laboratory of Biomembrane and Membrane Biotechnology and Beijing Key Laboratory of Cardiometabolic Molecular Medicine and PKU-IDG/McGovern Institute for Brain Research, Institute of Molecular Medicine and Peking-Tsinghua Center for Life Sciences, Peking University, Beijing, China
| | - Lie-Cheng Wang
- State Key Laboratory of Biomembrane and Membrane Biotechnology and Beijing Key Laboratory of Cardiometabolic Molecular Medicine and PKU-IDG/McGovern Institute for Brain Research, Institute of Molecular Medicine and Peking-Tsinghua Center for Life Sciences, Peking University, Beijing, China
| | - Wei Xiong
- State Key Laboratory of Biomembrane and Membrane Biotechnology and Beijing Key Laboratory of Cardiometabolic Molecular Medicine and PKU-IDG/McGovern Institute for Brain Research, Institute of Molecular Medicine and Peking-Tsinghua Center for Life Sciences, Peking University, Beijing, China
| | - Zhuan Zhou
- State Key Laboratory of Biomembrane and Membrane Biotechnology and Beijing Key Laboratory of Cardiometabolic Molecular Medicine and PKU-IDG/McGovern Institute for Brain Research, Institute of Molecular Medicine and Peking-Tsinghua Center for Life Sciences, Peking University, Beijing, China
| |
Collapse
|
3
|
Zhang B, Zhang XY, Luo PF, Huang W, Zhu FP, Liu T, Du YR, Wu QH, Lü J, Xiu Y, Liu LN, Huang HP, Guo S, Zheng H, Zhang CX, Zhou Z. Action potential-triggered somatic exocytosis in mesencephalic trigeminal nucleus neurons in rat brain slices. J Physiol 2011; 590:753-62. [PMID: 22124145 DOI: 10.1113/jphysiol.2011.221051] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/11/2022] Open
Abstract
The neurons in the mesencephalic trigeminal nucleus (MeV) play essential roles in proprioceptive sensation of the face and oral cavity. The somata of MeV neurons are generally assumed to carry out neuronal functions but not to play a direct role in synaptic transmission. Using whole-cell recording and membrane capacitance (C(m)) measurements, we found that the somata of MeV neurons underwent robust exocytosis (C(m) jumps) upon depolarization and with the normal firing of action potentials in brain slices. Both removing [Ca(2+)](o) and buffering [Ca(2+)](i) with BAPTA blocked this exocytosis, indicating that it was completely Ca(2+) dependent. In addition, an electron microscopic study showed synaptic-like vesicles approximated to the plasma membrane in somata. There was a single Ca(2+)-dependent releasable vesicle pool with a peak release rate of 1912 fF s(-1). Importantly, following depolarization-induced somatic exocytosis, GABA-mediated postsynaptic currents were transiently reduced by 31%, suggesting that the somatic vesicular release had a retrograde effect on afferent GABAergic transmission. These results provide strong evidence that the somata of MeV neurons undergo robust somatic secretion and may play a crucial role in bidirectional communication between somata and their synaptic inputs in the central nervous system.
Collapse
Affiliation(s)
- Bo Zhang
- State Key Laboratory of Biomembrane Engineering and the Centre for Life Sciences, Institute of Molecular Medicine, Peking University, Beijing 100871, China
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
4
|
Abstract
P2X and P2Y nucleotide receptors are described on sensory neurons and their peripheral and central terminals in dorsal root, nodose, trigeminal, petrosal, retinal and enteric ganglia. Peripheral terminals are activated by ATP released from local cells by mechanical deformation, hypoxia or various local agents in the carotid body, lung, gut, bladder, inner ear, eye, nasal organ, taste buds, skin, muscle and joints mediating reflex responses and nociception. Purinergic receptors on fibres in the dorsal spinal cord and brain stem are involved in reflex control of visceral and cardiovascular activity, as well as relaying nociceptive impulses to pain centres. Purinergic mechanisms are enhanced in inflammatory conditions and may be involved in migraine, pain, diseases of the special senses, bladder and gut, and the possibility that they are also implicated in arthritis, respiratory disorders and some central nervous system disorders is discussed. Finally, the development and evolution of purinergic sensory mechanisms are considered.
Collapse
|
5
|
Abstract
This review is focused on purinergic neurotransmission, i.e., ATP released from nerves as a transmitter or cotransmitter to act as an extracellular signaling molecule on both pre- and postjunctional membranes at neuroeffector junctions and synapses, as well as acting as a trophic factor during development and regeneration. Emphasis is placed on the physiology and pathophysiology of ATP, but extracellular roles of its breakdown product, adenosine, are also considered because of their intimate interactions. The early history of the involvement of ATP in autonomic and skeletal neuromuscular transmission and in activities in the central nervous system and ganglia is reviewed. Brief background information is given about the identification of receptor subtypes for purines and pyrimidines and about ATP storage, release, and ectoenzymatic breakdown. Evidence that ATP is a cotransmitter in most, if not all, peripheral and central neurons is presented, as well as full accounts of neurotransmission and neuromodulation in autonomic and sensory ganglia and in the brain and spinal cord. There is coverage of neuron-glia interactions and of purinergic neuroeffector transmission to nonmuscular cells. To establish the primitive and widespread nature of purinergic neurotransmission, both the ontogeny and phylogeny of purinergic signaling are considered. Finally, the pathophysiology of purinergic neurotransmission in both peripheral and central nervous systems is reviewed, and speculations are made about future developments.
Collapse
Affiliation(s)
- Geoffrey Burnstock
- Autonomic Neurscience Centre, Royal Free and University College Medical School, London, UK.
| |
Collapse
|